Results 81 to 90 of about 483,425 (231)

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.

New England Journal of Medicine, 1995
BACKGROUND Allogeneic or autologous bone marrow transplantation and intensive consolidation chemotherapy are used to treat acute myelogenous leukemia in a first complete remission.
R. Zittoun, F. Mandelli, R. Willemze, T. D. de Witte, B. Labar, L. Resegotti, F. Leoni, E. Damasio, G. Visani, G. Papa, F. Caronia, M. Hayat, P. Stryckmans, B. Rotoli, P. Leoni, M. Peetermans, M. Dardenne, M. L. Vegna, M. Petti, G. Solbu, S. Suciu   +20 more
semanticscholar   +1 more source

P1365: DONOR LYMPHOCYTE INFUSION IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: RESULTS FROM A RETROSPECTIVE STUDY

HemaSphere, 2022
D. Rochate, F. Vasconcelos, E. Couto, P. Silva Coelho, L. Leite, R. Branca, S. Roncón, C. Pinho Vaz, A. Campos   +8 more
doaj   +1 more source

mTOR inhibition improves the immunomodulatory properties of human bone marrow mesenchymal stem cells by inducing COX-2 and PGE2

Stem Cell Research & Therapy, 2017
Background Bone marrow mesenchymal stem cells (MSCs) are promising candidates for the treatment of various inflammatory disorders due to their profound immunomodulatory properties.
Binsheng Wang, Yu Lin, Yongxian Hu, Wei Shan, Senquan Liu, Yulin Xu, Hao Zhang, Shuyang Cai, Xiaohong Yu, Zhen Cai, He Huang   +10 more
doaj   +1 more source

Efficient Estimation of Semiparametric Transformation Models for the Cumulative Incidence of Competing Risks [PDF]

arXiv, 2016
The cumulative incidence is the probability of failure from the cause of interest over a certain time period in the presence of other risks. A semiparametric regression model proposed by Fine and Gray (1999) has become the method of choice for formulating the effects of covariates on the cumulative incidence.
arxiv  

Inflammation and Bone Marrow Transplantation

Biology of Blood and Marrow Transplantation, 2009
The procedural requirements of bone marrow transplantation (BMT) predispose to the dramatic induction of local and systemic inflammatory states and can be conceived in relation to transplant conditioning, the activation of alloreactive T cells and finally, the effector stage of graft-versus-host disease (GVHD).
openaire   +4 more sources

Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.

New England Journal of Medicine, 1991
BACKGROUND In early 1990 fluconazole was introduced as a prophylactic antifungal agent after bone marrow transplantation. During the same year Candida krusei emerged as the chief candida pathogen among patients with bone marrow transplants.
J. Wingard, W. Merz, M. G. Rinaldi, T. Johnson, J. Karp, R. Saral   +5 more
semanticscholar   +1 more source

P1372: REAL-WORLD RETROSPECTIVE ANALYSIS OF INFECTIOUS COMPLICATIONS AFTER RUXOLITNIB USE IN ACUTE AND CHRONIC GRAFT-VERSUS-HOST DISEASE

HemaSphere, 2022
C. Sol Reis, D. Duarte, I. Brito, P. Silva Coelho, L. Leite, R. Branca, S. Roncon, C. Pinho Vaz, A. Campos   +8 more
doaj   +1 more source

Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing Factors

Hepatology, 1984
Venocclusive disease (VOD) of the liver, a fibrous obliteration of small hepatic venules, can be caused by chemoradiation therapy. We reviewed 255 consecutive patients undergoing bone marrow transplantation for malignancy during 1978 to 1980 in order to ...
G. McDonald, Pankaj Sharma, David Matthews, H. Shulman, E. Thomas   +4 more
semanticscholar   +1 more source

P887: IN-HOUSE ANTI BCMA CAR-T THERAPY FOR THE TREATMENT OF RELAPSED REFRACTORY MULTIPLE MYELOMA: PHASE 1 RESULTS.

HemaSphere, 2022
N. Asherie, S. Kfir-Erenfeld, B. Avni, S. Grisariu, M. Assayag, T. Sharon, E. Lebel, C. J. Cohen, M. E. Gatt, P. Stepensky   +9 more
doaj   +1 more source

P1373: TACKLING IMMUNOLOGICAL FINDINGS AS SURROGATE MARKERS OF HISTOLOGICAL SEVERITY AND RESPONSE TO THERAPY IN ACUTE GASTROINTESTINAL GRAFT-VERSUS-HOST DISEASE

HemaSphere, 2022
M. Sousa-Pimenta, J. Freitas, E. Couto, P. Coelho, R. Branca, C. Pinho Vaz, L. Leite, A. Campos   +7 more
doaj   +1 more source